LifeMD Files 8-K: Regulation FD & Financials
Ticker: LFMDP · Form: 8-K · Filed: Nov 5, 2025 · CIK: 948320
| Field | Detail |
|---|---|
| Company | Lifemd, INC. (LFMDP) |
| Form Type | 8-K |
| Filed Date | Nov 5, 2025 |
| Risk Level | low |
| Pages | 4 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $0.0001, $4.6 m |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, financials, corporate-history
Related Tickers: LFMD
TL;DR
LifeMD dropped an 8-K on Nov 5, 2025, covering Reg FD and financials. Check it out.
AI Summary
LifeMD, Inc. filed an 8-K on November 5, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Conversion Labs, Inc. and Immudyne, Inc., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing provides important updates on regulatory disclosures and financial statements, which are crucial for investors to assess the company's current standing and compliance.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, typically for disclosures and financial statements, without immediate indication of significant new risks.
Key Players & Entities
- LifeMD, Inc. (company) — Registrant
- November 5, 2025 (date) — Date of earliest event reported
- Conversion Labs, Inc. (company) — Former company name
- Immudyne, Inc. (company) — Former company name
- Delaware (jurisdiction) — State of incorporation
- New York (location) — Business address city
FAQ
What specific Regulation FD disclosures are being made in this 8-K filing?
The filing indicates 'Regulation FD Disclosure' as an item, but the specific details of the disclosure are not provided in the provided text snippet.
What financial statements and exhibits are included with this 8-K filing?
The filing lists 'Financial Statements and Exhibits' as an item, but the specific content of these statements and exhibits is not detailed in the provided text.
When was LifeMD, Inc. previously known as Conversion Labs, Inc.?
The date of the name change from Conversion Labs, Inc. to LifeMD, Inc. was June 22, 2018.
What is LifeMD, Inc.'s fiscal year end?
LifeMD, Inc.'s fiscal year ends on December 31.
What is the SEC file number for LifeMD, Inc.?
The SEC file number for LifeMD, Inc. is 001-39785.
Filing Stats: 1,324 words · 5 min read · ~4 pages · Grade level 13.2 · Accepted 2025-11-05 17:27:46
Key Financial Figures
- $0.01 — ch registered Common Stock, par value $0.01 per share LFMD The Nasdaq Global Ma
- $0.0001 — ve Perpetual Preferred Stock, par value $0.0001 per share LFMDP The Nasdaq Global M
- $4.6 m — of these changes will be approximately $4.6 million, or approximately 1.4% of cumulat
Filing Documents
- form8-k.htm (8-K) — 52KB
- ex99-1.htm (EX-99.1) — 19KB
- ex99-1_001.jpg (GRAPHIC) — 3KB
- 0001493152-25-020913.txt ( ) — 288KB
- lfmd-20251105.xsd (EX-101.SCH) — 4KB
- lfmd-20251105_def.xml (EX-101.DEF) — 26KB
- lfmd-20251105_lab.xml (EX-101.LAB) — 36KB
- lfmd-20251105_pre.xml (EX-101.PRE) — 25KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFEMD, INC. Dated: November 5, 2025 By: /s/ Marc Benathen Marc Benathen Chief Financial Officer